San Jose, CA, United States of America

Deepak Kulkarni

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Deepak Kulkarni: Innovator in Content Authorization Systems

Introduction

Deepak Kulkarni is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of software applications, particularly in managing content authorization systems. With a total of 3 patents, his work has had a considerable impact on how applications handle permission data.

Latest Patents

One of Deepak's latest patents is focused on managing content authorization in a federated application system. This computer-implemented method involves receiving permission data from an application server for an account to access a software application among a plurality of software applications. The application server is designed to provide the software application. Upon receiving the permission data, it is stored in a native database. When a request is made to grant the account access to the software application, the system determines whether the database contains the necessary permission data. If the data is present, access is granted to the account.

Career Highlights

Deepak has worked with prominent companies such as Atlassian Corporation Pty Ltd. and Atlassian Inc. His experience in these organizations has allowed him to refine his skills and contribute to innovative solutions in software development.

Collaborations

Some of Deepak's notable coworkers include Jeffrey Lawrence Farber and Sidney Gee-Lake Shek. Their collaboration has likely fostered an environment of creativity and innovation.

Conclusion

Deepak Kulkarni's contributions to content authorization systems demonstrate his expertise and commitment to innovation in the software industry. His patents reflect a deep understanding of application security and user access management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…